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Abstract 
The TF cell line, derived from a carnivorous marine teleost, the turbot (Scophthalmus 
maximus), is known to have a reduced rate of polyunsaturated fatty acid (PUFA) biosynthesis. 
In order to establish the enzymic step responsible, the metabolic conversions of a range of 
PUFA including the key intermediates of n-3PUFA metabolism, stearidonic acid (18:4n-3) 
and its elongation product 20:4n-3, were studied in TF cells and compared with the AS cell 
line derived from Atlantic salmon (Salmo salar). Cells were cultured in the presence of 
unlabelled (25 µM), [U-14C] (1 µM/0.25 µCi) or deuterated (d5; 25 µM) fatty acids. The 
metabolism of stearidonic acid was qualitatively similar in both cell lines, predominantly 
elongation to 20:4n-3 with subsequent desaturation to eicosapentaenoic acid (20:5n-3), but 
there were significant quantitative differences. The alternative techniques and mass 
concentrations of substrates used gave different amounts of overall conversion, but all the 
results were consistent with an apparent partial deficiency in C18 to C20 fatty acyl elongation in 
TF cells compared to AS cells. In contrast, Δ5 desaturation was apparently greater in TF cells 
than in AS cells. Only small amounts of docosahexaenoic acid (22:6n-3) were produced by 
either cell line, although there was significant production of 22:5n-3, especially when 20:4n-3 
was supplemented to cultures.   From the results obtained in this study it is concluded that 
there is an apparent partial deficiency of  C18 to C20 fatty acyl elongation in the turbot cell line 
and that this, rather than lower fatty acyl Δ5 desaturation, may contribute to the reduced rate of 
conversion of 18:3n-3 to 20:5n-3 observed in the turbot compared with salmonid fish in vivo. 
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1. Introduction 
Vertebtrate animals lack the Δ12 and Δ15 fatty acyl desaturase enzymes responsible for 
the production of 18:2n-6 and 18:3n-3 from 18:1n-9 and so these essential fatty acids (EFA) 
are required in the diet and serve as the precursors for the longer-chain, more unsaturated 
polyunsaturated fatty acids (PUFA) characteristic of animal cells [1-4]. PUFA are essential 
components of biological membranes that have a role in the gross structural functions of the 
membrane, such as fluidity, and also have a considerable impact on the activity and function 
of membrane-associated proteins including receptors and enzymes [1-4]. PUFA themselves 
are precursors of a whole range of highly biologically active derivatives such as eicosanoids 
that are important in various forms of cell signalling [5-8]. Therefore, PUFA have important 
roles in both normal physiology and many pathological conditions. The EFA 
desaturation/elongation pathways in animals are still to be fully characterised as evidenced by 
the recent work suggesting that the production of 22:6n-3 proceeded without the Δ4 desaturase 
activity classically thought to be responsible for introduction of the final double bond [9]. 
Studies of these pathways have been greatly facilitated by the use of cell lines [10]. 
The EFA requirements of freshwater and marine fish are qualitatively different. For 
example, in the freshwater rainbow trout (Oncorhynchus mykiss)18:3n-3 alone can satisfy the 
EFA requirement, with 18:2n-6 only required for optimal growth [11]. However, in most 
marine species, including turbot (Scophthalmus maximus), the longer chain PUFA 20:5n-3 and 
22:6n-3 are required [12]. This suggested a species difference in fatty acid desaturase/elongase 
activities and it was subsequently shown that this in vivo difference was also present in 
cultured cell lines [13]. Studies involving supplementation of turbot cells (TF) in culture, 
compared to both rainbow trout cells (RTG-2) and Atlantic salmon cells (AS), with various n-
3 and n-6 PUFA had shown that the deficiency in the desaturase/elongase pathway in turbot 
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was either in the C18 to C20 elongase (C18-20 elongase) or the fatty acyl Δ5 desaturase step 
[13,14]. Studies performed on turbot in vivo were also inconclusive but more consistent with a 
deficiency in the Δ5 desaturase activity as the fish appeared unable to produce specifically the 
Δ5 desaturation products 20:4n-6 and 20:5n-3 [12,15]. In addition, results from in vivo studies 
with other marine fish species such as gilthead sea bream (Sparus aurata) and golden grey 
mullet (Liza aurata) were consistent with a deficiency in Δ5 desaturation [16,17]. Reduced 
flux through  desaturase/elongase pathways due to reduced desaturase activities have 
precedents in terrestrial carnivores such as cats in which Δ6 and Δ5 desaturase activities may 
both be severely limited [18-21]. It was hypothesised that this situation may be an 
evolutionary response to differences in diet. Therefore, whereas the natural diets of the 
generally more herbivorous/omnivorous freshwater fish, such as the well-studied salmonids, 
are relatively rich in C18 PUFA and do not contain much C20 or C22 PUFA, marine fish like the 
highly carnivorous turbot consume diets rich in 20:5n-3 and 22:6n-3 and so do not require to 
biosynthesise these PUFA [22,23]. 
As the situation in marine fish was unclear, we aimed to further define the enzymic 
location limiting the desaturase/elongase pathway in the turbot cell line. We report here the 
metabolism of various PUFA, including the key intermediates 18:4n-3 and 20:4n-3, in the TF 
and AS cell lines and that there was an apparent partial deficiency in  C18-20 elongation and not 
Δ5 desaturation in TF cells. 
 
2. Materials and methods 
Materials 
Unlabelled 18:4n-3 was purchased from Sigma Chemical Co. Ltd. (Poole, UK); its 
purity, checked by gas chromatography, was 91.5% with the remainder being 20:5n-3 (4.5%), 
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unidentified 18:4 isomer (2.5%), 20:3n-6 (1.1%) and 20:2n-6 (0.4%). Unlabelled 20:4n-3 
(>95%) was obtained from Cayman Chemical Company (Ann Arbor, MI, USA). [1-14C] fatty 
acids (18:1n-9, 18:2n-6, 20:3n-6, 18:3n-3 and 20:5n-3; all 50-55 mCi/mmol and > 98% purity) 
were obtained from NEN Life Science Products Ltd. (Hounslow, U.K). Sodium 
[14C]bicarbonate (~ 50 mCi/mmol) was purchased from ICN Biomedicals Ltd. (Thame, UK). 
Deuterated (d5-17,17,18,18,18)18:3n-3 ethyl ester was purchased from Cambridge Isotope 
Laboratories Inc., Andover, MA, USA. Thin layer chromatography (TLC) (20 cm x 20 cm x 
0.25 mm) and high-performance TLC (HPTLC) (10 cm x 10 cm x 0.25 mm) plates, pre-coated 
with silica gel 60 were obtained from Merck, (Darmstadt, Germany). All solvents were of 
HPLC grade (Rathburn Chemicals, Walkerburn, Peebleshire, Scotland). Ecoscint A was 
purchased from National Diagnostic (Atlanta, Georgia). L-15 Medium Leibovitz, Hanks’ 
balanced salt solution (HBSS), fetal bovine serum (FBS), G/P/S (200 mM L-glutamate, 10000 
U penicillin and 10 mg streptomycin per ml of 0.9% NaCl), HEPES buffer, fatty acid-free 
bovine serum albumin (FAF-BSA) and trypsin/EDTA were obtained from Sigma Chemical 
Co. Ltd. (Poole, UK). 
Cell lines and medium 
The Atlantic salmon (Salmo salar) cell line (AS) [24] and the turbot (Scophthalmus 
maximus) cell line (TF) were as described previously [25]. Both were maintained at 22°C in 
Leibovitz L-15 medium supplemented with 10 mM HEPES buffer, 2mM glutamine, 
antibiotics (50 IU/ml penicillin and 50 mg/ml streptomycin) and 10% FBS. 
Preparation of fatty acid/bovine serum albumin (BSA) complexes 
Fatty acid/BSA complexes were prepared by dissolving 10 mg of fatty acid in 100 µl 
0.1M KOH and stirring for 10 min before adding 5 ml of 50 mg/ml FAF-BSA in HBSS and 
stirring the mixture for 45 min at 20°C. The fatty acid/BSA complexes were filtered (0.2 µm - 
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Flowpore D22) into sterile vials and the fatty acid concentration determined after extraction by 
addition of a known amount of 17:0 free fatty acid, transmethylation and analysis by gas 
chromatography (GC). 
Incubation of cell cultures with polyunsaturated fatty acids 
Cell cultures were routinely grown in 75 cm2 flasks in medium containing 10% FBS and 
subcultured into medium containing 2% FBS 24 h prior to experimentation. All experiments 
were performed in triplicate with 6 flasks per sample for unlabelled fatty acids and one flask 
per sample for isotope experiments. All cultures used were subconfluent and growth continued 
during the experimental period.  Unlabelled fatty acids were added at a concentration of 25 
µM as BSA complexes in 70 µl of medium with control flasks receiving the same quantity of 
BSA solution. [1-14C] fatty acids were added as BSA complexes (0.25 µCi/flask); [U-14C] 
18:4n-3, obtained as methyl ester, was complexed with BSA and added to cells as described 
earlier. Because of the low yield that characterised the production of [U-14C] 20:4n-3 and of 
deuterated (d5) fatty acids in cell cultures and therefore the little mass available, these 
substrates were not added as BSA complexes, but directly as methyl esters in 50 µl of ethanol, 
to avoid the filtration step. [U-14C] 20:4n-3 methyl ester was added at 0.13 µCi per flask. 
18:4n-3 d5 and 20:4n-3 d5 methyl esters were added as 10% and 5% of total fatty acid 
respectively, after appropriate dilution with corresponding unlabelled methyl esters. 
The details of the fatty acid substrates added to the cell cultures are summarised in Table 
1. Preliminary experiments incubating AS cells with 25µM unlabelled 18:4n-3 as fatty acid 
salt/BSA complex, as methyl ester/BSA complex and as methyl ester in ethanol, showed no 
difference in the metabolism to 20:4n-3 and 20:5n-3 after 6 days of culture, therefore these 
three chemical forms of substrate can be considered equivalent for the purpose of the present 
study. No accumulation of methyl esters was found in the lipid composition of cells incubated 
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with methyl esters, compared to fatty acid salt/BSA complexes. 
Lipid extraction and analysis 
Medium was removed by aspiration, cells washed with 5 ml phosphate buffered saline 
and then dissociated with 0.05% trypsin/ 0.02% EDTA solution. Cells were harvested in 3 ml 
HBSS, centrifuged at 300g for 5 min at 4°C, resuspended in 5 ml HBSS and 50 µl taken for 
protein determination [26]. After centrifuging, cells were washed with 5 ml HBSS containing 
1% FAF-BSA, prior to extraction with 5 ml ice-cold chloroform/methanol (2:1, v/v) 
containing 0.01% butylated hydroxytoluene as antioxidant, according to Folch et al. [27]. 
Lipid was determined gravimetrically and resuspended in chloroform/methanol (as above) at a 
concentration of 10 or 100 mg/ml and stored at -20°C under argon. 
Separation and quantification of lipid classes was performed by single-dimension 
double-development HPTLC followed by scanning densitometry as described previously [28]. 
Fatty acid methyl esters (FAME) were prepared by acid-catalysed transmethylation, extracted 
and purified by HPTLC as described previously [29]. Analysis of FAME was performed by 
GC in a Fisons GC8000 gas chromatograph (Crawley, UK) equipped with a fused-silica 
capillary column (30m x 0.32 mm i.d., CP Wax 52 CB, Chrompack, UK) using hydrogen as 
carrier gas. Temperature programming was from 50 to 150°C at 35°C/min and to 225°C at 
2.5°C/min. Individual FAME were identified by comparison with known standards and 
published data [30,31]. 
For radioisotope experiments, FAME were prepared as above and separated by 
argentation chromatography on TLC plates impregnated with 2 g silver nitrate in 20 ml 
acetonitrile and activated at 110°C for 30 min. Plates were developed with toluene/acetonitrile 
(95:5, v/v) to separate PUFA [32] and autoradiography was performed using Kodak BioMax 
MR film for 6 days at room temperature. Bands corresponding to individual FAME, identified 
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in comparison with known standards, were scraped from the plate and assayed for 
radioactivity by scintillation counting (TRI-CARB 2000CA, United Technologies Packard, 
Pangbourne, UK). Data were corrected for quench and counting efficiency determined. For 
[U-14C]18:4n-3 metabolism, the identity of radioactive fatty acids recovered from cell 
incubations was also confirmed by capillary radio-GC, by repeating the incubations with a 
higher concentration of substrate (1µCi/flask). 
Total lipid FAME of samples incubated with deuterated fatty acids were analysed by GC 
as above and the identity of deuterated fatty acids confirmed by GC mass-spectrometry (MS). 
Where the concentrations of deuterated fatty acids were too low to be determined in this way, 
FAME were derivatised to pentafluorobenzyl esters [33] and quantified by negative chemical 
ionisation GC-MS using 17:0 and 23:0 as internal standards. Briefly, fatty acid esters in 
hexane were separated on an MD800 mass spectrometer linked to a GC8000 GC (Fisons 
Instruments Ltd., Crawley, UK) equipped with a CP Wax 52CB fused silica capillary column 
(30 m x 0.32 mm i.d.; Chrompack, London, UK) and on-column injection using methane as 
carrier gas at a source pressure of 4 x 10-4 torr. The source temperature was 150 oC, the 
transfer line was maintained at 260 oC and the GC oven temperature programme was 50 oC to 
190 oC at 40 oC/min, then to 240 oC at 1.5 oC and held for 20 min. Details of the MS analysis 
were as described previously by Pawlosky et al. [33]. 
Preparation  of [U-14C]18:4n-3 and [U-14C]20:4n-3 
 [U-14C]18:4n-3 was obtained from cultures of the unicellular marine alga Isochrysis 
galbana  (Parke) (S.M.B.A. strain No. 58 C.C.A.P. strain 927/1) grown in 300 ml of f/2 media 
[34] containing 2.5 mCi of sodium [14C]bicarbonate for 9 days at 20°C under constant light 
(100 µE s-1). Cells were harvested by centrifugation at 2500 g for 5 min and the algal pellet 
extracted with chloroform/propan-2-ol (2:1, v/v) [27]. Over 1 mCi of radioactivity was 
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recovered in the total lipid extract (13 mg). The total lipid was applied to a TLC plate, 
chromatographed in diethyl ether, dried under vacuum and developed a second time in methyl 
acetate/propan-2-ol/ chloroform /methanol/ 0.25% aqueous KCl (25:25:25:10:9, by vol.) [35].  
After desiccation, mono- and di-galactosyldiacylglycerols (MGDG and DGDG) were detected 
under UV light after spraying with 0.1% 2',7'-dichlorofluorescein (DCF) in 97% methanol, the 
silica scraped and lipids transmethylated directly on the silica as above. FAME were extracted 
as described previously [29], quantified gravimetrically and radioactivity determined as 
described above. 25.1 µCi were recovered in 0.63 mg FAME from MGDG and 11.2 µCi were 
recovered in 0.29 mg FAME from DGDG. FAME were separated by argentation TLC as 
above and the individual FAME bands identified after 1 h autoradiography. The silica 
containing 18:4n-3 was scraped from the plate, 5 ml 2% aqueous NaCl added and the silica 
extracted 6 times with 10 ml hexane/diethyl ether (1:1, v/v) and once with 20 ml chloroform/ 
methanol (2:1, v/v) to elute FAME. Pooled fractions were dried and radioactivity determined 
as above. A total of 5 µCi of [U-14C]18:4n-3 was obtained, with a specific activity of 
approximately 12 mCi/mmol. The identity of the 18:4n-3 was confirmed and its purity (>99%) 
checked by radio-gas chromatography as described by Buzzi et al. [36]. 
[U-14C]20:4n-3 was biosynthesised by incubating AS cells (10 x 162 cm2 flasks) for 6 
days with [U-14C]18:4n-3 (0.45 µCi per flask), added as a BSA complex in 50 µl of medium. 
Cells were recovered and extracted as for fatty acid metabolism and [U-14C]20:4n-3 separated 
from transmethylated total lipid fatty acid by argentation TLC as for 18:4n-3. Almost 1 µCi of 
[U-14C]20:4n-3 with a specific activity of approximately 12 mCi/mmol and > 99% purity, 
determined by radio-GC, was obtained. 
Preparation  of deuterated (d5)18:4n-3 and (d5)20:4n-3  
Deuterated (d5)18:4n-3 methyl ester was obtained from TF cells (6 x 75 cm2 flasks) 
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incubated for 6 passages with (d5)18:3n-3 ethyl ester (25 µM added in 12 µl ethanol to each 
flask at each passage). Cell harvesting, lipid extraction and transmethylation of total lipid were 
performed as described above. The methyl ester of 18:4n-3 was separated by reverse-phase 
HPLC (C18 column, 25 x 1cm, 5 mm particle size; Altex Beckman, U.S.A) using acetonitrile 
(flow rate 1.5 ml/min), and detected at 215 nm. The identity and purity of fractions was 
determined by GC and the concentration of deuterated 18:4n-3 methyl ester was quantified 
using 17:0 as an internal standard. Unlabelled 18:4n-3 methyl ester was added to produce the 
concentration intended for use in experiments. 
Deuterated (d5)20:4n-3 methyl ester was obtained from AS cells (6 x 75 cm2 flasks) 
incubated for 6 passages with (d5)18:4n-3 methyl ester. HPLC separation was performed as 
previously described, but as 20:4n-3 coeluted with 16:2n-9, the sample was 
rechromatographed using methanol/water (97:3, v/v) at the same flow rate. Identity, purity and 
adjustment of concentration was performed as described above. 
Statistical analysis 
Results are presented as means ± SD (n = 3 or 4). The data were checked for 
homogeneity of the variances by the Bartlett test and, where necessary, the data were arc-sin 
transformed before further statistical analysis.  Differences between mean values were 
analysed by the Student t-test or one-way analysis of variance (ANOVA), followed when 
pertinent by a multiple comparison test (Tukey). Differences were reported as statistically 
significant when P < 0.05 [37]. 
 
3. Results 
Effects of 18:4n-3 and 20:4n-3 on cell growth, lipid content and composition  
Supplementation of TF and AS cells with 18:4n-3 and 20:4n-3 at final concentrations of 
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25 µM did non influence the proliferation rate of cells, nor their lipid content, as shown in 
Table 2. The only difference detected between the two cell lines was in the culture density, 
higher for TF than for AS cells as the latter are bigger cells. The ratio between the lipid and 
protein content of both cell lines was constant under all conditions (0.2 mg lipid/ mg protein), 
indicating that no extra lipid deposition occurred in the cells due to supplementation with these 
fatty acids at the concentration used. Consistent with this, the lipid class compositions, which 
were very similar in TF and AS cells, were not significantly changed by supplementation with 
18:4n-3 and 20:4n-3. The majority of lipids were polar lipids (72%) with the neutral lipids 
being predominantly cholesterol (23%). Phosphatidylcholine was the most abundant 
phospholipid (30% of total lipid), followed by phosphatidylethanolamine (19%), 
phosphatidylinositol (7.5%) and phosphatidylserine (7%). 
Effects of 18:4n-3 and 20:4n-3 on fatty acid compositions 
The fatty acid profiles of total lipids from TF and AS cells in control cultures (2% FCS) 
and cultures supplemented with 25 µM 18:4n-3 or 20:4n-3 are shown in Table 3. Total PUFA 
were only slightly increased in supplemented TF cells, whereas PUFA more than doubled in 
supplemented AS cells, compared to control cultures. PUFA of the n-3 series were increased 
in supplemented TF cells (up to 19-21% from 8%) and supplemented AS cells (up to 27-29% 
from 6%), compared to controls. Supplementation with 18:4n-3 increased18:4n-3 (from about 
zero to 8% in TF and 12% in AS) and 20:5n-3 (from 0.5% to 3% in TF and from 0.8% to 5% 
in AS) in both cell lines, whereas 20:4n-3 was only increased (zero to 5%) in AS cells. 
Similarly, supplementation with 20:4n-3 increased the percentages of 20:4n-3 (from 
approximately zero to 3% in TF and from zero to 12% in AS) and 20:5n-3 (from 0.5% to 6% 
in TF and from 0.8% to 7% in AS) in both cell lines. Supplementation with 20:4n-3 also 
increased 18:4n-3 (to 3% in TF and 2.2% in AS) in both cell lines. The percentage of 22:5n-3 
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was increased in both cell lines, particularly when 20:4n-3 was supplemented, whereas 22:6n-
3 levels remained unaltered. 
The increased percentages of n-3PUFA were balanced by decreased percentages of 
monoenes, predominantly 18:1n-9, in AS cells whereas in TF cells, although monoenes were 
decreased, the main balancing reduction was in n-9PUFA, predominantly 18:2n-9, which were 
reduced in supplemented cells (from 20% to 12-13%) (Table 3). PUFA of the n-6 series were 
only slightly decreased in 20:4n-3 supplemented cells in both lines. Saturated fatty acids were 
generally increased in supplemented cells, particularly TF cells, primarily due to increased 
18:0. 
Metabolism of [1-14C]18:3n-3, [U-14C]18:4n-3, [U-14C]20:4n-3 and [1-14C]20:5n-3  
The metabolism of the n-3PUFA is presented as percentages of the total radioactivity 
recovered in individual PUFA (Table 4). With [1-14C]18:3n-3, it is evident that, although the 
percentage of unmetabolised substrate is similar in both cells lines, the majority (64%) was 
simply desaturated to 18:4n-3 in TF cells whereas almost 55% was both desaturated and 
further elongated in AS cells. [U-14C]18:4n-3 was mainly unaltered in TF cells (73%), whereas 
over 81% was chain elongated in AS cells with 24% of radioactivity recovered in 20:4n-3 and 
48% in 20:5n-3. In contrast, only 4% of radioactivity was recovered in 20:4n-3 and 16% in 
20:5n-3 in TF cells incubated with [U-14C]18:4n-3. In contrast, more [U-14C]20:4n-3 was 
desaturated to 20:5n-3 in TF cells (51%) than in AS cells (34%), where it mostly remained as 
20:4n-3 (56%). Some chain shortening of [U-14C]20:4n-3 to 18:4n-3 was observed in both cell 
lines. The metabolism of [1-14C]20:5n-3 was similar in TF and AS cells, most of it being 
retained as unmetabolised substrate. The main metabolite was its elongated product 22:5n-3 
which accounted for about 9% of radioactivity recovered in both cell lines. 
Metabolism of [1-14C]18:1n-9, [1-14C]18:2n-6 and [1-14C]20:3n-6 
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The results show that more [1-14C]18:1n-9 was metabolised in TF cells (35% 
unmetabolised) than in AS cells (77% unmetabolised) and that in TF the substrate was mainly 
desaturated to 18:2n-9 (39%) (Table 5). Similarly, more 18:2n-6 was unmetabolised in AS 
cells (71%) than in TF cells (50%), with 18:3n-6 the predominant product in TF cells (38%) 
while 20:3n-6 was the most abundant metabolite in AS cells (12%). Approximately twice as 
much [1-14C]20:3n-6 was desaturated to 20:4n-6 and elongated to 22:3n-6 in TF cells 
compared to AS cells. 
Metabolism of deuterated 18:3n-3, 18:4n-3 and 20:4n-3 
The results for the metabolism of deuterated fatty acids are presented in a similar way to 
the metabolism of 14C-labelled fatty acids, i.e. data are percentages (by weight) of total 
deuterated fatty acids recovered in total lipids (Table 6). 
Approximately 5-fold more (d5)18:4n-3 was elongated to 20:4n-3 in AS cells compared 
to TF cells although comparable amounts of 20:5n-3 were found in both cell lines.  In contrast, 
twice as much (d5) 20:4n-3 was recovered as the Δ5 desaturated product, 20:5n-3, in TF cells 
(42%) compared to only 19% in AS cells. 
Chain shortened products were generally more prominent in AS cells than TF cells 
(Table 6). For (d5)18:4n-3, twice as much deuterated 16:4n-3 was detected in AS cells 
compared to TF. The same fatty acid was also present in cells incubated with (d5)20:4n-3, 
again at higher levels in AS (11%) than in TF (7%), although comparable percentages of 
deuterated 18:4n-3 were detected. 
Individual metabolic steps in desaturation/elongation pathway 
A summary of the results obtained in the isotopic experiments, derived from the data 
contained in Tables 4-6, is presented in Table 7. The amounts of the products of each 
individual step in the desaturation/elongation pathway were summed taking into account all 
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the fatty acids that are a result of that step, irrespective of subsequent conversions. The results 
obtained for each enzymatic process when incubating the cells with the fatty acid which is the 
direct substrate (i.e. 18:4n-3 for C18-20 elongase and 20:4n-3 for Δ5 desaturase) are of particular 
interest as they are an indication of the potential activity of each enzyme independent of the 
effects of enzymes preceding it in the pathway. 
Table 7 shows C18-20 elongase products are always lower in TF cells than in AS cells for 
both n-6 and n-3 substrates, and this is particularly evident with the direct substrate, 18:4n-3, 
both radioactive (26% in TF and 81% in AS) and deuterated (10% in TF and 19% in AS). In 
contrast, Δ5 products are higher in TF cells compared to AS cells (65% v. 40%, 71% v. 31% 
and 10% v. 6%, respectively) when a direct substrate is given to the cells ([U-14C]20:4n-3, 
(d5)20:4n-3 and [1-14C]20:3n-6, respectively). Similarly, Δ6 desaturase activity is higher in TF 
cells than in AS cells although the activity towards [1-14C]18:3n-3 was comparable.  C20-22 
elongase products are also higher in TF cells incubated with [1-14C]20:3n-6, [U-14C]20:4n-3 or 
(d5)20:4n-3 compared to AS cells (13% v. 8%, 19% v. 8% and 15% v. 5%, respectively) or at 
least comparable, as shown in the incubations with [1-14C]20:5n-3 (approximately 12% for 
both cell lines). 
 
4. Discussion 
The present study attempted to establish the enzyme responsible for reduced flux in the 
fatty acid desaturation/elongation pathway in a cell line, TF, derived from turbot. In order to 
do this, the direct substrates for all the component enzymes in the pathway were required so 
that each step could be assayed and determined in isolation from the influence of preceding 
enzymes in the pathway. As isotopes for two crucial fatty substrates, 18:4n-3 (the direct 
substrate for C18-20 elongase) and 20:4n-3 (the direct substrate for Δ5 desaturase) were not 
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available commercially they had to be synthesised before supplementation to TF and AS cells 
and analysis of the metabolic products. Therefore, the investigation focused on the metabolism 
of these two key intermediate fatty acids and in so doing suggested a likely biochemical cause 
for the lower rates of overall conversion in the marine fish, the turbot, when compared with 
the salmonid, the Atlantic salmon. 
All the results, using unlabelled, [1-14C]-, [U-14C]- and (d5)-labelled fatty acids, are 
consistent with the fact that the TF cell line has a partial deficiency or reduced rate of C18-20 
elongation, while Δ5 desaturase activity is apparently greater than in the AS cell line. In an 
earlier study on the TF cell line, “an apparent deficiency in the C18 to C20 elongase 
multienzyme complex” was hypothesised as the reason for the low conversion of 18:3n-3 to 
20:5n-3 [13]. However, studies in vivo [12,15], together with the general belief that desaturase 
activities were more likely to be controlled and, therefore, the rate limiting steps in 
desaturation/elongation pathways [38] together with evidence that terrestrial carnivores 
appeared to lack, or express relatively low Δ6 and, possibly, Δ5 desaturases [18] led to the 
proposition that the Δ5 desaturase activity would be deficient in carnivorous marine fish in 
general, including turbot and sea bream (Sparus aurata L.) [16]. Only the use of isotopically 
labelled fatty acid intermediates could attempt to discriminate between the two hypotheses of 
reduced Δ5 desaturation or reduced C18-20 elongation. 
         The present results, suggesting that TF cells have a partial deficiency in  C18-20 elongation 
would be consistent with the known EFA requirements of turbot. However, Maeda et al. [39] 
found that three out of six mammalian cell lines had lost Δ6 desaturase activity, Δ5 desaturase 
activity appeared to be absent in four cell lines and only one cell line expressed any desaturase 
activity beyond Δ5. There is also evidence for loss of stearoyl-CoA Δ9 desaturase in murine T 
lymphocytes in culture [40]. Therefore, loss or down -regulated activities in the desaturase/ 
 16 
elongase pathway may be a common feature of cell lines, and so it is prudent to be cautious in 
translating the results in cell culture to in vivo.  In consequence, it is important to determine 
that this situation in TF cells is the one in vivo, and that TF cells are a model for the whole 
animal, via experiments with deuterated substrates similar to those performed by other authors 
in felines [41,42] and humans [43,44]. 
       Cell culture studies have proved very useful in determining the potential effects of fatty 
acid supplementation on cellular fatty acid compositions as a more rapid and less expensive 
alternative to dietary trials with whole animals [13]. Therefore, the incubations with unlabelled 
18:4n-3 and 20:4n-3 at 25 µM showed the effects of these fatty acids on the fatty acid 
compositions of TF and AS cells. Previously, we established that a fatty acid concentration of 
25 µM in the medium alters the membrane phospholipid fatty acid composition of the cells 
without affecting the lipid class composition or precipitating the appearance of cytoplasmic 
lipid droplets [13]. The (d5) isotopes were also used at 25 µM enabling the metabolism of the 
supplemented fatty acid to be determined under conditions known to affect fatty acid 
compositions. This is in contrast to the radiotracer studies where concentrations of fatty acid 
rarely exceed 1 µM, a concentration which has little impact on cellular fatty acid 
compositions. It is therefore noteworthy that the data obtained from all the experiments were 
generally consistent and qualitatively similar although there were quantitative differences 
between tracer experiments and those using a significant mass of fatty acid substrate.  In the 
latter case, the effects of cellular fatty acid composition in altering enzyme substrate 
concentrations and inhibitory processes such as product inhibition are evident.      
There are few data in the literature describing the metabolism via 
desaturation/elongation of either 18:4n-3 or 20:4n-3 by other cell lines.  However, incubation 
of NIH-3T3 cells with approximately 70µM unlabelled 18:4n-3 resulted in the accumulation 
 17 
in phospholipids of primarily 20:5n-3 (15%) and 20:4n-3 (11%) followed by 18:4n-3 (10%) 
and 22:5n-3 (4%), whereas the percentage of 22:6n-3 was only slightly increased [45]. This 
pattern was similar to AS cells except the percentages were higher in NIH-3T3 cells possibly 
due to a mass effect, as discussed above, as the level of 18:4n-3 supplemented to the 3T3 cells 
was almost 3-fold greater.  This also resulted in significant deposition of fatty acids, including 
20:4n-3, 18:4n-3 and 20:5n-3, in triacylglycerols which were increased from trace amounts to 
almost 16% of total cellular lipid [45], whereas there was no accumulation of fatty acid in 
neutral lipid and no accumulation of any neutral lipid class, including triacylglycerols, in the 
present study.  In a separate feeding study, rats were fed a lipid-free diet supplemented with 
either 1% 18:3n-3-ethyl ester or 1% 18:4n-3-ethyl ester and the effects on fatty acid 
compositions of plasma and liver lipid fatty acid compositions determined [46]. The molar 
ratio of 20:5n-3 in most lipid fractions was approximately 2-fold higher in the rats fed 18:4n-3, 
and 18:4n-3 was found in the liver lipids in only very small amounts suggesting that it was 
rapidly metabolised to 20:5n-3 and that Δ6 desaturase was the limiting step in the production 
of 20:5n-3 from 18:3n-3 [46]. 
Apparently higher levels of Δ6 desaturation were observed in the TF cell line compared 
to the AS cell line. Higher Δ6 desaturase activity in TF cells, compared to another cell line, 
RTG-2 from trout, had been reported previously [13], but is more interesting with the 
observation that TF also showed apparently higher Δ5 desaturase activity than AS cells.  
However, increased cellular levels of 18:2n-6 may inhibit Δ6 desaturation [47] and, as the 
level of 18:2n-6 is slightly higher in AS cells than in TF cells, this this may be a contributing 
factor.   The use of sequential substrates clearly demonstrated how the previous enzyme in the 
desaturation/elongation pathway can affect the apparent activity of subsequent enzymes. For 
instance, with both [1-14C]18:3n-3 and [U-14C]18:4n-3, the results could suggest that AS cells 
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had higher Δ5 desaturase activity than TF cells but this is shown to be highly dependent on the 
preceding activities with reduced C18-20 elongase activity in TF cells.  
In conclusion, the present results provide evidence that TF cells have a partial deficiency 
in  C18-20 elongation which would be consistent with the known EFA requirements of turbot.  
However, it is important to determine that this situation is the one in vivo, and that TF cells are 
a model for the whole animal, so appropriate in vivo experiments perhaps similar to those 
performed in felines and humans are required [41-44]. 
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